Advanced search
Publication Cover
Clinical Toxicology Volume 59, 2021 - Issue 3
Submit an article Journal homepage
666
Views
5
CrossRef citations to date
0
Altmetric
Clinical Research

Long term use of donepezil and QTc prolongation

Jason Khoa Department of Cardiology and Internal Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UKORCID Iconhttps://orcid.org/0000-0003-3377-4750
ORCID Icon,
Adam Ioannoub Royal Free Hospital, Royal Free London NHS Foundation Trust, Camden, UK
,
Amit K. J. Mandala Department of Cardiology and Internal Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK
,
Andrew Coxa Department of Cardiology and Internal Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK
,
Ashraf Nasima Department of Cardiology and Internal Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK
,
Sofia Metaxaa Department of Cardiology and Internal Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK
&
Constantinos G. Missourisa Department of Cardiology and Internal Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK;c Medical School, University of Cyprus, Nicosia, CyprusCorrespondence[email protected]
 show all
Pages 208-214 | Received 12 May 2020, Accepted 20 Jun 2020, Published online: 01 Jul 2020

References

  • Kitt J, Irons R, Al-Obaidi M, et al. A case of donepezil-related torsades de pointes. BMJ Case Rep. 2015;2015:bcr2015211900.
  • Mandal AKJ, Khan UF, Missouris CG. Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil. Clin Toxicol. 2019;57(12):1157–1159.
  • Malik BH, Hamid P, Khan S, et al. Correlation between donepezil and QTc prolongation and torsades de pointes: a very rare phenomenon. Cureus. 2019;11(12):e6451.
  • Takaya T, Okamoto M, Yodoi K, et al. Torsades de Pointes with QT prolongation related to donepezil use. J Cardiol. 2009;54(3):507–511.
  • Bordier P, Garrigue S, Barold SS, et al. Significance of syncope in patients with Alzheimer’s disease treated with cholinesterase inhibitors. Europace. 2003;5(4):429–431.
  • Hernandez RK, Farwell W, Cantor MD, et al. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. J Am Geriatr Soc. 2009;57(11):1997–2003.
  • Bordier P, Garrigue S, Lanusse S, et al. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer’s disease. CNS Drugs. 2006;20(5):411–417.
  • Igeta H, Suzuki Y, Tajiri M, et al. Cardiovascular pharmacodynamics of donepezil hydrochloride on the PR and QT intervals in patients with dementia. Hum Psychopharmacol Clin Exp. 2014;29(3):292–294.
  • Wang D, Wu Y, Wang A, et al. Electrocardiogram changes of donepezil administration in elderly patients with ischemic heart disease. Cardiol Res Pract. 2018;2018:9141320.
  • Donepezil Hydrochloride: side-effects [Internet]. London (UK): BMJ Group and Pharmaceutical Press; 2020 [Accessed on 2020 April 16]. Available from: http://www.medicinescomplete.com
  • Aricept (Donepezil Hydrochloride) [Internet]. New Hampshire (MD): United States Food and Drug Administration; 2012 [Accessed on 2020 April 16]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf
  • Rowland JP, Rigby J, Harper AC, et al. Cardiovascular monitoring with acetylcholinesterase inhibitors: a clinical protocol. Adv Psychiatr Treat. 2007;13(3):178–184.
  • Chan A, Isbister GK, Kirkpatrick CM, et al. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM. 2007;100(10):609–615.
  • Talbot S. QT interval in right and left bundle-branch block. Br Heart J. 1973;35(3):288–291.
  • Roden DM. Keep the QT interval: it is a reliable predictor of ventricular arrhythmias. Heart Rhythm. 2008;5(8):1213–1215.
  • Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36(6):1749–1766.
  • Li K, Cheng N, Li XT. Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel. Sci Rep. 2017;7:41509.
  • Isik AT, Bozoglu E, Yay A, et al. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer’s disease? Am J Alzheimers Dis Other Demen. 2012;27(3):171–174.
  • Rabkin SW, Cheng XJ, Thompson DJ. Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol. 2016;13(9):740–748.
  • Rabkin SW. Impact of age and sex on QT prolongation in patients receiving psychotropics. Can J Psychiatry. 2015;60(5):206–214.
  • Tan MP, Newton JL, Reeve P, et al. Results of carotid sinus massage in a tertiary referral unit–is carotid sinus syndrome still relevant? Age Ageing. 2009;38(6):680–686.
  • Kumar NP, Thomas A, Mudd P, et al. The usefulness of carotid sinus massage in different patient groups. Age Ageing. 2003;32(6):666–669.
  • Kerr SR, Pearce MS, Brayne C, et al. Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls. Arch Intern Med. 2006;166(5):515–520.
  • Tsutsui JM, Falcão SN, Dourado PM, Lima MF, et al. Gender differences in chronotropic and hemodynamic responses during dobutamine-atropine stress echocardiography. Echocardiography. 2007;24(8):843–850.
  • Sato K, Urbano R, Yu C, et al. The effect of donepezil treatment on cardiovascular mortality. Clin Pharmacol Ther. 2010;88(3):335–338.
  • Park-Wyllie LY, Mamdani MM, Li P, et al. Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med. 2009;6(9):e1000157.
  • Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet. 2004;363(9427):2105–2115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.